We describe the labeling of adult neural stem cells (aNSCs) in the mouse and human dentate gyrus (DG) by the combinatorial expression of glial fibrillary acidic protein (GFAP) and Prominin1, as revealed by immunohistochemistry. Split-Cre-based genetic fate mapping of these double-positive cells in the adult murine DG reveals their NSC identity, as they are self-renewing and contribute to neurogenesis over several months. Their progeny reacts to stimuli such as voluntary exercise with increased neurogenesis. Prominin1+/GFAP+ cells also exist in the adult human DG, the only region in the human brain for which adult neurogenesis has been consistently reported. Our data, together with previous evidence of such double-positive NSCs in the developing murine brain and in neurogenic regions of vertebrates with widespread neurogenesis, suggest that Prominin1-and GFAP-expressing cells are NSCs in a wide range of species in development and adulthood.
INTRODUCTION
Since the discovery of adult neural stem cells (aNSCs), the extent to which stem cells have common hallmarks, either in the same tissue from development into adulthood or across different adult tissues, has been a key issue. The transcription factor SOX2, the intermediate filament protein Nestin, and the membrane protein Prominin1 have been suggested as common molecular markers for NSCs across different regions and ontogenies (Lendahl et al., 1990; Suh et al., 2007; Weigmann et al., 1997) . However, these markers are rather widespread in the adult brain, with SOX2 being expressed in all astrocytes (Suh et al., 2007) and Nestin and Prominin1 present in all ependymal cells lining the ventricle (Beckervordersandforth et al., 2010; Coskun et al., 2008) .
To overcome the problems associated with the promiscuity of a single marker, we previously applied a combinatorial approach to detect and isolate radial glial cells (i.e., NSCs) in developing and adult mouse brains (Götz and Huttner, 2005; Kriegstein and Alvarez-Buylla, 2009 ) by their glial identity (e.g., GLAST (Ninkovic et al., 2007) , GFAP (Morshead et al., 2003) , and human GFAP [hGFAP]-eGFP) and coexpression of Prominin1 (Pinto et al., 2008; Beckervordersandforth et al., 2010) , a membrane-associated glycoprotein that is expressed in neurogenic regions of other vertebrates with widespread neurogenesis (Jászai et al., 2013) . This approach allowed not only purification of NSCs in the developing brain (Pinto et al., 2008) but also enrichment of aNSCs from the subependymal zone (SEZ; Beckervordersandforth et al., 2010) .
Little is known about Prominin1 localization on adult NSCs in the dentate gyrus (DG), the only region where neurogenesis appears to persist prominently in the adult human brain (Sanai et al., 2011; Spalding et al., 2013) . Although Prominin1 is present in neurosphereforming cells from the adult murine hippocampus (Walker et al., 2013) , the relationship of Prominin1 with GFAP+ radial and horizontal astrocytes that act as NSCs in this region (Lugert et al., 2010) is less well understood. Here, we examined the extent of Prominin1 and GFAP coexpression in aNSCs in murine and human DG, and monitored the progeny of these cells by genetic fate mapping.
RESULTS
Prominin1 Is Expressed in Radial and Nonradial Glial Cells in the Subgranular Zone of the Adult Hippocampus Prominin1 maps to loci that promote neurogenesis in the DG (Kempermann et al., 2006) , and was recently shown to be expressed in most neurosphere-forming cells of the 
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Labeling Neural Stem Cells with Prominin1 and GFAP hippocampus (Walker et al., 2013) . To examine the colocalization of Prominin1 with GFAP, we immunostained adult hippocampal sections of hGFAP-eGFP transgenic mice. Interestingly, we found that Prominin1 immunoreactivity was restricted to the DG ( Figure 1A) , where it localized along the radial process and soma of radial astrocytes (Figure 1A) , horizontal astrocytes in the subgranular zone (SGZ), and some astrocytes in the hilus. Prominin1+ radial astrocytes showed high levels of hGFAP-eGFP ( Figure 1A ) and coexpressed endogenous GFAP ( Figure 1B ), Nestin (Figure 1C) , and SOX2 ( Figure 1E ). All Nestin-immunoreactive radial astrocytes were positive for Prominin1, while 40% of the radial astrocytes expressed both Prominin1 and hGFAP-eGFP. Very few Prominin1+/hGFAP-eGFP+ cells were positive for S100b, which labels postmitotic astrocytes, and no colocalization with the intermediate progenitor (IP) marker TBR2 ( Figure S1A available online) or the neuroblast (NB) marker Doublecortin (DCX) was detectable ( Figure 1D ; summarized in Figure 1F ). hGFAP-eGFP+ cells that lacked Prominin1 comprised many other cell types, such as parenchymal astrocytes in the molecular layer (ML), the granular zone (GZ), and the hilus (GFAP in Figure 1B ), and were S100b immunoreactive ( Figure 1F ), consistent with a more mature astrocyte identity (Raponi et al., 2007) . A small proportion of DCX+ NBs and immature neurons ( Figure 1D ) were Prominin1À and had weaker GFP signals than radial and other astrocytes, consistent with the idea that they inherited the GFP from their ancestors but had turned off the activity of the hGFAP promoter (Beckervordersandforth et al., 2010; Pinto et al., 2008) . We also observed Prominin1+ radial cells that were negative for hGFAP-eGFP and DCX, but positive for GFAP ( Figure 1B ), Nestin ( Figure 1C ), and SOX2 ( Figure 1F ). In the SGZ, Prominin1+/hGFAP-eGFP+ cells consisted of radial and horizontal astrocytes coexpressing aNSC proteins such as SOX2 and Nestin, whereas the population that was positive for only one of the markers comprised many more cell types within and beyond the DG.
Prominin1+/hGFAP-eGFP+ Cells Are Bromodeoxyuridine-Label Retaining in the Adult Murine DG Next, we examined the extent to which the Prominin1+/ hGFAP-eGFP+ cells were bromodeoxyuridine (BrdU)-label retaining, which is a property of slow-dividing aNSCs (Lugert et al., 2010) . BrdU was provided in drinking water for hGFAP-eGFP mice (2 weeks to 2 months old) to label the cells that divided in this time window, followed by a 2 week BrdU-free chase period. In this paradigm, slowdividing aNSCs and postmitotic progeny such as neurons are labeled, but the latter can be distinguished by costaining for neuronal markers. Indeed, most of the BrdU-labeled cells were positive for DCX (76%, n = 242 BrdU+ cells, 4 animals), indicative of an NB or immature neuron identity (Figure 2A ), whereas some BrdU+ cells expressed GFAP (Figure 2B) . We found that 3% of the BrdU-label-retaining cells (n = 845 BrdU+ cells, 4 animals) were Prominin1+/hGFAPeGFP+ ( Figures 2C and 2D) . Conversely, 29.8% of the Prominin1+/hGFAP-eGFP+ radial astrocytes retained the BrdU label, consistent with their slow mode of cell division (n = 120 Prominin1+/hGFAP-eGFP+ cells, 4 animals). Some BrdU+ cells were colabeled with either Prominin1 or hGFAP-eGFP alone (3.9% and 4.4%, respectively; Figure 2C; n = 845 BrdU+ cells, 4 animals). The latter category comprised DCX+ cells as well as GFAP+ astrocytes, consistent with the finding that some dividing aNSCs can give rise to astrocytes (Encinas et al., 2011) . Few BrdU-labelretaining cells coexpressed the cell-cycle marker KI67, implying that they reentered the cell cycle ( Figure 2E ). Since these cells were hGFAP-eGFP+ with long radial processes that were always labeled with Prominin1 ( Figure 1A ), we conclude that this population is BrdU-label retaining and represents self-renewing aNSCs.
In Vivo Targeting of aNSCs in the DG by a Split-Cre Approach Next, we performed a fate-mapping analysis of Prominin1+/hGFAP+ cells to assess lineage and self-renewal. For this purpose, we employed the split-Cre approach (Hirrlinger et al., 2009) , in which the C-terminal half of the Cre recombinase is driven by the Prominin1 P2 promoter and inserted into one lentiviral vector, while the N-terminal half of Cre is driven by hGFAP promoter elements and inserted into a second lentiviral vector (Beckervordersandforth et al., 2010) . We injected the two lentiviruses into the DG of 2-month-old CAG CAT GFP reporter mice and assessed the identity of the recombined cells by immunohistochemistry along with morphological criteria and localization. The recombined cells were analyzed shortly after the injection (3 days postinjection [dpi]) to determine their identity and at later time points (7 dpi, and 1 and 3 months postinjection [mpi]) to monitor their progeny. At 3 dpi, the majority of the reporter-positive cells were GFAP+ (88.2%; n = 272 GFP+ cells in 3 different animals). In the SGZ, the majority of GFP+/GFAP+ cells had a radial or horizontal morphology (Figures 3A and 3B ; Table S1 ) consistent with the suggestion that the DG contains morphologically distinct aNSC populations (Lugert et al., 2010) . We also observed some GFP+ astrocytes in the hilus and GZ (Figures  3A and 3B ; Table S1 ), similar to the results from immunostaining described above, and very few in the ML. At this early time point and 7 dpi (data not shown), none of the recombined cells were colabeled with TBR2 ( Figure S1B ; Table S1 ) or DCX ( Table S1 ), showing that the starting population does not comprise the progeny of aNSCs, as previously indicated by other approaches (Bonaguidi et al., 2011; Lagace et al., 2007) . It also reveals that the labeled aNSCs were largely quiescent, as their progeny 7 days after labeling had not yet passed to the early steps of the neuronal lineage, such as IPs and early NBs.
By 1 mpi, GFP+/DCX+ NBs with the typical immature granule neuron morphology had emerged from the GFPexpressing population ( Figure 3C ), demonstrating that some cells that were initially labeled by the split-Cre approach had generated immature neurons by this time (see also Figures 4A and 4C) . Notably, even at 1 mpi, GFAP+ radial and horizontal astrocytes were still the majority of GFP+ cells, further supporting their quiescent nature. Interestingly, in some instances of low-density infection, we observed GFP+ cell clusters, possibly clonally derived cells, consisting of a GFAP+ radial astrocyte in close proximity to a GFAPÀ cell and several NBs ( Figure 3D) .
At 3 mpi, GFP+/GFAP+ cells with radial and horizontal morphology reminiscent of the initial population (Figure 3H ; Table S1 ) persisted in the SGZ, indicating some degree of self-renewal. We could still detect GFP+ NBs expressing DCX, suggesting that they were recently generated and had not yet fully matured (11%; n = 1680 GFP+ cells, 3 animals; Figures 3E and 3F; Table S1 ). Most importantly, many mature GFP+/NEUN+ neurons were observed, accounting for 47% of the GFP+ cells (Figures 3G and 3H ; Table S1 ), consistent with the further maturation of the NBs generated at earlier stages. Notably, glial cells did not increase in the SGZ and GZ populations, implying that the labeled cells were largely neurogenic even in 5-month-old mice. These results strongly suggest that glial cells coexpressing Prominin1 and hGFAP in the SGZ of the adult DG are long-term neurogenic and self-renewing aNSCs.
It has been shown that physical activity increases neurogenesis by effects on various stages of the lineage (Brandt et al., 2010; Lugert et al., 2010; Steiner et al., 2008) . To test whether the Prominin1+/hGFAP+ lineage also responds to a running stimulus, mice were housed with free access to running wheels directly after the injection of split-Cre viruses and analyzed at 1 mpi. In agreement with previous findings, the number of newly generated GFP+/DCX+ NBs was more than doubled in the running mice in comparison to the nonrunners (Figures 4A-4C ; Table S1 ). Thus, SGZ NBs expanded at the expense of non-SGZ glia, whereas the SGZ glia showed no obvious difference. These data demonstrate that the Prominin1+/ hGFAP+ lineage reacts to voluntary exercise by increasing the generation of new neurons as previously described for quiescent aNSCs (Lugert et al., 2010) .
Human Prominin1+/GFAP+ Cells in Human DG
Because the combination of Prominin1 and GFAP labels NSCs in all neurogenic regions of the mouse brain, we investigated the expression of both markers in the postmortem human brain. hGFAP is expressed by many astrocytes of the human hippocampus. Interestingly, we found a very selective localization of human Prominin1 (hProminin1) along radial and nonradial GFAP+ processes ( Figures 4D-4F ) in the human DG. This coexpression was consistently observed irrespective of the age of the subject (between 51 and 87 years; Figures 4D-4F and S2A-S2C) . Thus, the adult human DG also harbored cells coexpressing GFAP and Prominin1, similar to neurogenic regions in other mammalian and nonmammalian vertebrates.
DISCUSSION
During brain development, aNSCs originate from their region-specific embryonic counterparts, suggesting common hallmarks between embryonic and adult radial glial cells. We previously showed that Prominin1 in combination with hGFAP is a highly selective marker for NSCs in the embryonic forebrain and the adult SEZ (Beckervordersandforth et al., 2010; Pinto et al., 2008) . Here, we extended this labeling technique to the DG and demonstrated that Prominin1+/hGFAP+ cells are long-term, self-renewing aNSCs that increase the generation of new neurons upon physical activity. These data, together with our expression analysis in human DG samples and the widespread expression of Prominin1 in neurogenic zones of other vertebrates (Jászai et al., 2013) , strongly suggest that the combinatorial expression of hGFAP and Prominin1 is a widespread marker for NSCs in many species and at different developmental stages.
In comparison with our approach, previous analyses of aNSCs in the DG by different single-marker-labeling strategies had the disadvantage of targeting other cell types in D, F, and G) . GZ, granular zone; ML, molecular layer. See also Figure S1 and Table S1 . Figure S2C ); magnification of boxed areas in (E and F). (E) Colocalization of hProminin1 and hGFAP (arrows) in radially oriented glial cells in the DG as well as in other glial processes (F). Scale bars, 100 mm (A and B) and 20 mm (D-F). See also Figure S1 and Table S1 .
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Labeling Neural Stem Cells with Prominin1 and GFAP nonradial aNSCs while excluding NSC progeny, is an important improvement that allows us to analyze stem cell characteristics and lineage progression under specific conditions (e.g., age, disease, running, and learning).
Interestingly, Prominin1 is found in other adult stem cell populations, such as those in the hematopoietic system and small intestine (Snippert et al., 2009; Zhu et al., 2009) and is a marker of tumor-initiating cells in several cancers (Neuzil et al., 2007) . It was originally discovered in humans as an antibody against the AC133 antigen (Shmelkov et al., 2005) , a glycosylation-dependent epitope of CD133. Prominin1+ cells isolated from the adult human kidney were shown to be capable of self-renewal and multilineage differentiation, and to contribute to renal tissue regeneration (Bussolati et al., 2005) . Our finding that Prominin1 is expressed in both major sets of adult murine NSCs further supports its widespread presence in adult stem cell populations. Prominin1 has been implicated at the functional level in self-renewal of stem cells (Ettinger et al., 2011) . Its association with cholesterol-based membrane microdomains and protrusion-specific localization led to the hypothesis that Prominin1 plays a role in the biogenesis and functional maintenance of plasma membrane protrusions, and there is evidence that the release of Prominin1-containing membrane particles may contribute to cell differentiation (Corbeil et al., 2010) . Although the function of Prominin1 in embryonic and adult NSCs needs further investigation, here we substantiate the wide applicability of Prominin1 in combination with an additional tissue-specific antigen as a valuable tool for identifying stem cells.
EXPERIMENTAL PROCEDURES

Animals and Stereotactic Injections
hGFAP-eGFP (Nolte et al., 2001 ) and CAG CAT GFP reporter (Nakamura et al., 2006) mice were kept under standard housing conditions. For the voluntary exercise paradigm, running wheels were put in the cages. Experimental procedures were performed in accordance with German and European Union guidelines and were approved by the institutional animal care committee and the Government of Upper Bavaria under license number 55.2-1-54-2531-144/07. Stereotactic injections were performed as previously described (Jagasia et al., 2009 ) with 1 ml of virus per DG at the following coordinates: À2.0 anterior/posterior, ±1.6 medial/lateral, and À1.9 to À2.1 dorsal/ventral relative to bregma (in millimeters). Split-Cre viral constructs were as described in Beckervordersandforth et al. (2010) .
Human Tissue
Tissues were procured from patients who were admitted to the Department of Neuropathology, University of Debrecen, Debrecen, Hungary, and died between January and April 2011. The institutional review board and local ethics committee approved the study, and informed consent was obtained from the relatives of all patients analyzed.
Tissue collection (occipital cortex and hippocampus) was performed in subjects without neurological or psychiatric disease who died from nonneurological causes. Brain tissue was frozen and stored at À80 C until further analysis.
Immunohistochemistry
Animal handling, sectioning of brains, and immunohistochemistry are described in detail in the Supplemental Experimental Procedures.
The following primary antibodies were used: rat anti-CD133 (1:100; eBioscience), chicken anti-GFP (1:2000; Aves), mouse anti-GFAP (1:500; Sigma), rabbit anti-GFAP (1:500; DAKO), rabbit anti-DCX (1:500; abcam), guinea pig anti-DCX (1:500; Millipore), mouse anti-Nestin (1:200; Millipore), rabbit anti-SOX2 (1:500; Millipore), mouse anti-S100b (1:1000; Sigma), rat anti-BrdU (1:200; Serotec), mouse anti-BrdU (1:200; Becton Dickinson), mouse anti-KI67 (1:200; DAKO), mouse anti-NEUN (1:100; Millipore), rabbit anti-TBR2 (1:500; abcam), rabbit anti-human GFAP (1:1,000; DAKO), and mouse anti-human PROMININ1 (80B258; Karbanova et al., 2008) .
Primary antibodies were visualized with Alexa-conjugated secondary antibodies (all 1:400; Invitrogen). Biotinylated secondary antibodies (1:400; Vector Laboratories) were used in combination with Alexa-conjugated streptavidin (Invitrogen) to enhance CD133 and GFP signals. As a negative control, staining was done using secondary antibody only.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, two figures, and one table and can be found with this article online at http://dx.doi.org/10.1016/j.stemcr. 2014.01.004.
